Journal of Cardiac Failure
Volume 12, Issue 1 , Pages 39-46 , February 2006

Warfarin Versus Aspirin in Patients With Reduced Cardiac Ejection Fraction (WARCEF): Rationale, Objectives, and Design

  • Patrick Pullicino, MD

      Affiliations

    • Department of Neurology and Neurosciences, New Jersey Medical School, UMDNJ, Newark, New Jersey
    • Corresponding Author InformationReprint requests: Patrick Pullicino, MD, Room 105, KIMHS, Research and Development Centre, University of Kent, Canterbury CT2 7PD, United Kingdom.
    • ,
  • John L.P. Thompson, PhD

      Affiliations

    • Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York
    • ,
  • Bruce Barton, PhD

      Affiliations

    • Maryland Medical Research Institute, Baltimore, Maryland
    • ,
  • Bruce Levin, PhD

      Affiliations

    • Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York
    • ,
  • Susan Graham, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, State University of New York at Buffalo
    • ,
  • Ronald S. Freudenberger, MD

      Affiliations

    • Heart Failure and Transplant Cardiology Program, Department of Medicine, Robert Wood Johnson Medical School, New Brunswick, New Jersey
    • ,
  • on behalf of the WARCEF Investigators

Received 19 June 2003 ,Revised 20 July 2005 ,Accepted 22 July 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Funded by National Institutes of Health—National Institute of Neurological Disorders and Stroke, cooperative agreements U01 NS43975 and U01 NS39143Dr. Pullicino's current affiliation is Kent Institute of Medicine and Health Sciences, University of Kent, Canterbury, United Kingdom.

PII: S1071-9164(05)00715-3

doi: 10.1016/j.cardfail.2005.07.007

Journal of Cardiac Failure
Volume 12, Issue 1 , Pages 39-46 , February 2006

Article Tools

* Image Usage & Resolution